Ahmed Mohammed Shennawy

C-peptide in MASLD – a potential driver of hepatic steatosis and fibrosis

Metabolically-dysfunction-associated steatotic liver disease (MASLD), the leading chronic liver condition worldwide, is driven by hyperinsulinemia and insulin resistance, with C-peptide serving as a stable marker of endogenous insulin secretion. In this perspective, we propose to redefine C-peptide as an active driver...